October 18, 2017 | City of Hope
City of Hope will be the one of the first authorized centers in the nation to provide axicabtagene ciloleucel, which the U.S. FDA announced today is the first approved CAR-T therapy for adult patients for some types of non-Hodgkin lymphoma
October 18, 2017 | Letisia Marquez
A group of researchers in City of Hope’s Department of Experimental Therapeutics and Cal Tech may be one step closer to developing the first CMV vaccine for commercial use.
September 25, 2017 | City of Hope
City of Hope doctors and scientists have published a study in OncoImmunology about a triple-negative breast cancer patient whose disease regressed rapidly when she took part in an experimental treatment that combines a p53 cancer vaccine, which was developed at City of Hope, and a drug that blocks a specific cancer-aiding protein.
July 14, 2017 | Katie Neith
Two City of Hope research programs are among 13 projects to recently receive funding from the California Institute of Regenerative Medicine’s Discovery Quest Awards Program.
July 7, 2017 | Samantha Bonar
Sunita Patel, Ph.D., a neuropsychologist in the Population Sciences and Supportive Care Medicine departments at City of Hope, has received a $1.22 million grant from the American Cancer Society to test a new approach toward preventing long-term chemotherapy-related cognitive side effects.
June 29, 2017 | Katie Neith
Clinical trial results in positive outcomes for patients with relapsed or treatment-resistant disease. Hodgkin lymphoma is typically considered to be one of the most curable forms of cancer, but some with the disease relapse or find that their cancer is resistant to treatment. For patients like this, a fully human monoclonal antibody called avelumab has shown promising results in a phase 1 clinical trial for safety and efficacy.
June 20, 2017 | Samantha Bonar
Dan Rojas, 31, who has been living with HIV since 2011, is one of a handful of brave patients participating in a groundbreaking study at City of Hope that seeks a cure for AIDS.
June 19, 2017 | Samantha Bonar
Tracking patients using wireless wrist monitors like Fitbits is a good way to evaluate their recovery after major surgery, according to new research published in JAMA Surgery by City of Hope’s Virginia Sun, Ph.D., R.N., an assistant professor in the Division of Nursing Research and Education.
May 4, 2017 | Katie Neith
An international team of researchers led by City of Hope’s Defu Zeng believe they may have found a way to prevent graft-versus host disease following stem cell transplants without sacrificing the transplants’ ability to fight leukemia and lymphoma.